Advertisement

Topics

ABEC and WuXi Biologics Company Profile

23:55 EDT 22nd April 2018 | BioPortfolio

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and value proposition to our global clients. For more information on WuXi Biologics, please visit www.wuxibiologics.com.


News Articles [562 Associated News Articles listed on BioPortfolio]

WuXi Biologics to Install Largest SUB from ABEC

Selects 4,000L Custom Single Run disposable bioreactors for new commercial manufacturing facility in Wuxi

WuXi Biologics to Install Industry's Largest Single-Use Bioreactor from ABEC at its New Commercial Manufacturing Facility

WUXI, China and BETHLEHEM, Pa., March 21, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics ...

WuXi Biologics Initiated cGMP Manufacturing in the World's Largest Biologics Manufacturing ...

In April 2015, WuXi Biologics announced a $150 millionplan to build a state-of-the-art biologics manufacturing facility in Wuxi city. In September 2016, Read more...

WuXi Biologics to Install Industry’s Largest Single-Use Bioreactor from ABEC at its New Commercial Manufacturing Facility

WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufact...

WuXi Biologics bets on China’s MAH scheme with new facility

Chinese biologics services provider WuXi Biologics (HK: 2269) recently started the operation of a new…

WuXi Biologics adds 4,000L bioreactors at fully single-use site

The CMO says adding the single-use offering from ABEC will make the newly opened biomanufacturing site in China comparable to stainless steel for commercial mAb production.

WuXi Biologics To Be ‘World’s No.1’ Biologics Maker

WuXi Biologics is aiming high to become the world’s biggest biologics manufacturer within five years after seeing strong confidence from...   

BRIEF—Former FDA manager joins WuXi Biologics as chief quality officer

Hong Kong-listed WuXi Biologics has appointed former US FDA associate country manager Chiang Syin as…

PubMed Articles [103 Associated PubMed Articles listed on BioPortfolio]

Biologics for pityriasis rubra pilaris treatment: a review of the literature.

Pityriasis rubra pilaris (PRP) is a rare inflammatory papulosquamous skin disease, often refractory to conventional therapies. The off-label use of biologics, such as anti-TNF, -IL-12/IL-23, -IL-17 ag...

Facilitated recruitment of mesenchymal stromal cells by bone marrow concentrate and platelet rich plasma.

Biologics containing growth factors are frequently used to enhance healing after musculoskeletal injuries. One mechanism of action is thought to be though the ability of biologics to induce homing and...

Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.

Biologics have greatly improved psoriasis management. However, primary and secondary non-response to treatment requires innovative strategies to optimize outcomes.

Using insurance claims to predict and improve hospitalizations and biologics use in members with inflammatory bowel diseases.

Inflammatory Bowel Disease (IBD) is an inflammatory disorder of the gastrointestinal tract that can necessitate hospitalization and the use of expensive biologics. Models predicting these intervention...

A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULIN.

Many healthcare providers in the U.S. are not familiar with follow-on biologics and biosimilars nor with their critical distinctions from standard generics. Our aim is to provide a detailed review of ...

Clinical Trials [69 Associated Clinical Trials listed on BioPortfolio]

Serological Screening of Gastric Cancer in Wuxi Region

The purpose of this study is to determine whether detection of pepsinogen Ⅰand Ⅱ combined with Helicobacter pylori antibody, so-called ABC method , is fit on gastric cancer screening i...

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Companies [261 Associated Companies listed on BioPortfolio]

ABEC and WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover d...

ABEC Incorporated

ABEC designs and manufactures custom designed, turn-key manufacturing equipment for the pharmaceutical, bio-tech, animal health and food industries. Our products include fermentors, bio-reactors, clea...

WuXi PharmaTech (Cayman) Inc.

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused co...

WuXi PharmaTech, Ltd.

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused com...

WuXi AppTec

WuXi AppTec’s U.S. Manufacturing and Testing group provides a comprehensive range of integrated programs for biologics, advanced therapies and medical devices – along wi...

More Information about "ABEC and WuXi Biologics" on BioPortfolio

We have published hundreds of ABEC and WuXi Biologics news stories on BioPortfolio along with dozens of ABEC and WuXi Biologics Clinical Trials and PubMed Articles about ABEC and WuXi Biologics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ABEC and WuXi Biologics Companies in our database. You can also find out about relevant ABEC and WuXi Biologics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...


Corporate Database Quicklinks



Searches Linking to this Company Record